Back to Search
Start Over
A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome
- Source :
- Frontiers in Cellular Neuroscience, Frontiers in Cellular Neuroscience, Vol 14 (2020)
- Publication Year :
- 2020
- Publisher :
- Frontiers Media S.A., 2020.
-
Abstract
- Usher syndrome is a genetic disorder causing neurosensory hearing loss and blindness from retinitis pigmentosa (RP). Adaptive techniques such as braille, digital and optical magnifiers, mobility training, cochlear implants, or other assistive listening devices are indispensable for reducing disability. However, there is currently no treatment to reduce or arrest sensory cell degeneration. There are several classes of treatments for Usher syndrome being investigated. The present article reviews the progress this research has made towards delivering commercial options for patients with Usher syndrome.
- Subjects :
- 0301 basic medicine
Drug
medicine.medical_specialty
Hearing loss
Usher syndrome
media_common.quotation_subject
Review
adeno-associated virus
lcsh:RC321-571
03 medical and health sciences
Cellular and Molecular Neuroscience
0302 clinical medicine
Retinitis pigmentosa
medicine
otorhinolaryngologic diseases
ipscs
usher syndrome
Intensive care medicine
lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry
media_common
business.industry
gene editing
Genetic disorder
medicine.disease
Sensory cell
Braille
gene therapy
eye diseases
030104 developmental biology
Cellular Neuroscience
medicine.symptom
cell therapy
antisense oligonucleotides
business
030217 neurology & neurosurgery
Cell based
Subjects
Details
- Language :
- English
- ISSN :
- 16625102
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- Frontiers in Cellular Neuroscience
- Accession number :
- edsair.doi.dedup.....c2f8cef5b843327a9325f40ee52b8eef